| Name | Title | Contact Details |
|---|
Kansas City Art Statuary Inc is a Kansas City, MO-based company in the Manufacturing sector.
Cabot Corporation (NYSE: CBT) is a leading global specialty chemical and performance materials company headquartered in Boston, Massachusetts. We deliver performance solutions that solve customers` challenges today and prepare them to meet tomorrow`s needs.
Baxano Surgical is a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the spine affecting the lumbar region. We are committed to delivering minimally invasive surgical technologies that enhance patient clinical care while providing sustained value for our customers.
Over the past three decades, Drytac has evolved into one of the most highly regarded manufacturers of products for graphics finishing and display, with offices and distribution centres situated across the globe that allow us to serve a truly international marketplace. Our core product line consists of a wide range of pressure-sensitive, Heatset™ and thermal overlaminating films. In addition, we offer mounting adhesives, backing films, inkjet media, finishing equipment, liquid laminating systems, accessories, and banner stands. Our Start-to-Finish strategy sums up Drytac`s unique ability to manage all phases of the customer experience - product quality and performance; manufacturing and distribution; training and technical support; and the industry`s best customer service.
Verde Science has assembled an impressive team of scientists from highly technical disciplines including Bioprocess Technology, Nanotechnology, Molecular Virology and Immunology, Molecular Biology, Pharmacology and Medical Device Design. Our focus is the discovery of novel drugs and new treatment modalities, as well as cutting edge diagnostic devices and pharmaceutical delivery systems for the treatment of emerging diseases and contemporary medical issues where current treatments either do not exist or are inadequate. Our Research and Development program includes collaboration with our R&D alliance partners which include the Sterkem Group, an integrated pharmaceutical firm based in Mumbai, India; the Institute for Chemical Technology, a Mumbai, India based science and technology university; and our researchers based in India and Canada. We believe that this synergistic and nimble team of highly skilled scientists is the most cost-effective and efficient way to rapidly respond to the increasing array of inadequately addressed contemporary medical issues facing the world community. An initial focus is on developing custom medicinal formulations from cannabinoids and THC compounds for the treatment of specific issues such as migraines, glaucoma, loss of appetite from cancer therapies, and numerous other medical issues. Verde also plans to alpha test innovative growing technologies in India as part of the company’s initiatives.